Brind.
  1. Whitehawk Therapeutics, Inc. in-licensed assets from WuXi Biologics and participated in conferences in New York City on September 3, 2025.
  2. Whitehawk Therapeutics, Inc. in-licensed assets from WuXi Biologics and participated in conferences in New York City on September 3, 2025.
  3. Whitehawk Therapeutics, Inc. in-licensed assets from WuXi Biologics and participated in conferences in New York City on September 3, 2025.
  4. Whitehawk Therapeutics, Inc. in-licensed assets from WuXi Biologics and participated in conferences in New York City on September 3, 2025.

Whitehawk Therapeutics, Inc. in-licensed assets from WuXi Biologics and participated in conferences in New York City on September 3, 2025.

3 reports, 1 independent Updated Sep 2
Gone quiet
Reports
3
Developments
4
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Whitehawk Therapeutics, Inc. in-licensed assets from WuXi Biologics and participated in conferences in New York City on September 3, 2025.

Who's involved

What this event is mainly about
WuXi BiologicsNew York City

How it developed

Newest first. Tap a step to see who reported it.
  1. Whitehawk Therapeutics, Inc. in-licensed assets from WuXi Biologics and participated in conferences in New York City on September 3, 2025.Sub-event
  2. Whitehawk in-licensed assets from WuXi Biologics and participated in conferences in NYC.1 source
  3. WuXi Biologics received an upfront payment on the ADC agreement with Whitehawk Therapeutics.1 source
  4. Whitehawk in-licensed assets from WuXi Biologics and announced the partnership on LinkedIn.1 source

Keep exploring

Part of

Whitehawk Therapeutics, Inc. in-licensed assets from WuXi Biologics and participated in conferences in New York City on September 3, 2025. The whole story

Within Whitehawk Therapeutics, Inc. in-licensed assets from WuXi Biologics and participated in conferences in New York City on September 3, 2025.

The entities involved

Coverage

Newest first; wire copies grouped
  • PR NewswireWhitehawk Therapeutics to Participate in Upcoming Investor Conferences MORRISTOWN, N.J., Sept. 2, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company ap
  • PR NewswireWhitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights MORRISTOWN, N.J., Aug. 7, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology ther
  • PR NewswireWhitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference MORRISTOWN, N.J., July 22, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutic